142 related articles for article (PubMed ID: 8931747)
21. Epidemiology and prognostic determinants of patients with bacteremic cholecystitis or cholangitis.
Lee CC; Chang IJ; Lai YC; Chen SY; Chen SC
Am J Gastroenterol; 2007 Mar; 102(3):563-9. PubMed ID: 17335448
[TBL] [Abstract][Full Text] [Related]
22. Intra-abdominal anaerobic infections: bacteriology and therapeutic potential of newer antimicrobial carbapenem, fluoroquinolone, and desfluoroquinolone therapeutic agents.
Goldstein EJ
Clin Infect Dis; 2002 Sep; 35(Suppl 1):S106-11. PubMed ID: 12173118
[TBL] [Abstract][Full Text] [Related]
23. [Comparative study of prognostic and risk factors for mortality in polymicrobial bacteremia-fungemia in a university hospital: development over 10 years].
Ruiz-Giardín JM; Noguerado A; Pizarro A; Méndez J; La Hulla F; Fernández M; Hernández F; San Martín JV; Hernández I; Alvarez J; Salvanes F
Enferm Infecc Microbiol Clin; 2002 Nov; 20(9):435-42. PubMed ID: 12425877
[TBL] [Abstract][Full Text] [Related]
24. Bacteremia caused by Achromobacter and Alcaligenes species in 46 patients with cancer (1989-2003).
Aisenberg G; Rolston KV; Safdar A
Cancer; 2004 Nov; 101(9):2134-40. PubMed ID: 15389476
[TBL] [Abstract][Full Text] [Related]
25. The epidemiology of bacteremia with febrile neutropenia: experience from a single center, 1988-2004.
Paul M; Gafter-Gvili A; Leibovici L; Bishara J; Levy I; Yaniv I; Shalit I; Samra Z; Pitlik S; Konigsberger H; Weinberger M
Isr Med Assoc J; 2007 Jun; 9(6):424-9. PubMed ID: 17642387
[TBL] [Abstract][Full Text] [Related]
26. [Bacteremia caused by Stenotrophomonas maltophilia: a clinical-epidemiological study and resistance profile].
Ubeda P; Salavert M; Giner S; Jarque I; López-Aldeguer J; Pérez-Bellés C; Gobernado M
Rev Esp Quimioter; 1998 Sep; 11(3):205-15. PubMed ID: 9795306
[TBL] [Abstract][Full Text] [Related]
27. Population-based study of the risk and short-term prognosis for bacteremia in patients with liver cirrhosis.
Thulstrup AM; Sørensen HT; Schønheyder HC; Møller JK; Tage-Jensen U
Clin Infect Dis; 2000 Dec; 31(6):1357-61. PubMed ID: 11096002
[TBL] [Abstract][Full Text] [Related]
28. Clinical and microbiologic determinants of serious bloodstream infections in Egyptian pediatric cancer patients: a one-year study.
El-Mahallawy H; Sidhom I; El-Din NH; Zamzam M; El-Lamie MM
Int J Infect Dis; 2005 Jan; 9(1):43-51. PubMed ID: 15603994
[TBL] [Abstract][Full Text] [Related]
29. Polymicrobial bloodstream infection in pediatric patients: risk factors, microbiology, and antimicrobial management.
Sutter D; Stagliano D; Braun L; Williams F; Arnold J; Ottolini M; Epstein J
Pediatr Infect Dis J; 2008 May; 27(5):400-5. PubMed ID: 18398386
[TBL] [Abstract][Full Text] [Related]
30. Are incidence and epidemiology of anaerobic bacteremia really changing?
Vena A; Muñoz P; Alcalá L; Fernandez-Cruz A; Sanchez C; Valerio M; Bouza E
Eur J Clin Microbiol Infect Dis; 2015 Aug; 34(8):1621-9. PubMed ID: 26017663
[TBL] [Abstract][Full Text] [Related]
31. Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae bloodstream infection: risk factors and clinical outcome.
Du B; Long Y; Liu H; Chen D; Liu D; Xu Y; Xie X
Intensive Care Med; 2002 Dec; 28(12):1718-23. PubMed ID: 12447513
[TBL] [Abstract][Full Text] [Related]
32. Anaerobic bacteraemia in patients admitted to Auckland City Hospital: its clinical significance.
Muttaiyah S; Paviour S; Buckwell L; Roberts SA
N Z Med J; 2007 Nov; 120(1265):U2809. PubMed ID: 18264176
[TBL] [Abstract][Full Text] [Related]
33. Bloodstream infection surveillance in a cancer centre: a prospective look at clinical microbiology aspects.
Velasco E; Byington R; Martins CS; Schirmer M; Dias LC; Gonçalves VM
Clin Microbiol Infect; 2004 Jun; 10(6):542-9. PubMed ID: 15191383
[TBL] [Abstract][Full Text] [Related]
34. Factors associated with mortality in bacteremic patients with hematologic malignancies.
Tumbarello M; Spanu T; Caira M; Trecarichi EM; Laurenti L; Montuori E; Fianchi L; Leone F; Fadda G; Cauda R; Pagano L
Diagn Microbiol Infect Dis; 2009 Jul; 64(3):320-6. PubMed ID: 19345033
[TBL] [Abstract][Full Text] [Related]
35. Antibiotic-resistant bloodstream infections in hospitalized patients: specific risk factors in a high-risk population?
von Baum H; Ober JF; Wendt C; Wenzel RP; Edmond MB
Infection; 2005 Oct; 33(5-6):320-6. PubMed ID: 16258861
[TBL] [Abstract][Full Text] [Related]
36. Bloodstream infections caused by Enterobacter species: predictors of 30-day mortality rate and impact of broad-spectrum cephalosporin resistance on outcome.
Kang CI; Kim SH; Park WB; Lee KD; Kim HB; Oh MD; Kim EC; Choe KW
Clin Infect Dis; 2004 Sep; 39(6):812-8. PubMed ID: 15472813
[TBL] [Abstract][Full Text] [Related]
37. Early bacteremia in pediatric hematopoietic stem cell transplant patients on oral antibiotic prophylaxis.
Kersun LS; Propert KJ; Lautenbach E; Bunin N; Demichele A
Pediatr Blood Cancer; 2005 Aug; 45(2):162-9. PubMed ID: 15593235
[TBL] [Abstract][Full Text] [Related]
38. Retrospective analysis of clinical and microbiological aspects of Klebsiella oxytoca bacteremia over a 10-year period.
Kim BN; Ryu J; Kim YS; Woo JH
Eur J Clin Microbiol Infect Dis; 2002 Jun; 21(6):419-26. PubMed ID: 12111596
[TBL] [Abstract][Full Text] [Related]
39. Prognostic evaluation of bacteremia and fungemia in patients with acquired immunodeficiency syndrome.
Torres-Tortosa M; Canueto J; Bascuñana A; Vergara A; Sánchez-Porto A; Moreno-Maqueda I; López-Suárez A; González-Serrano M; Cruz E
Eur J Clin Microbiol Infect Dis; 2002 Apr; 21(4):262-8. PubMed ID: 12072936
[TBL] [Abstract][Full Text] [Related]
40. [Bacteremia: a Spanish multicenter study with 5000 cases. The Hospital Infection Study Group (GEIH)].
Sota Busselo M; Ezpeleta Baquedano C; Cisterna Cancer R
Rev Clin Esp; 1997 Dec; 197 Suppl 5():3-9. PubMed ID: 9558601
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
